Accelerating Texas K12 Education: TASA: Putting the Public Back into Public Education

With the education sector completely disrupted from the pandemic, school administration and students alike are feeling anxiety and pressure from the uncertainty and instability of the world. What does the ‘new normal’ look like for educating students? How are schools handling staff burnout? Answering these questions and more on Accelerating Texas K12 Education is Kevin Brown, executive director of Texas Association of School Administration (TASA).

TASA, an organization with a mission to develop educational leaders and support students, saw an opportunity to level up during the pandemic. While COVID-19 brought many challenges and hardships, Brown noted that there is a silver lining, like the added flexibility; a switch to social and emotional wellbeing; rapid technology integration and adaptation; and tailoring student learning to the individual.

“Maybe this is the shot in the arm that we needed in terms of getting schools to be transformation-thinking and really personalizing for individual students throughout our country,” Brown explained.

Unlike reforming schools, like in the early 1900s when schools were painstakingly standardized everything, 21st century learning will involve transforming schools that focuses on the individual and initiatives like implementing technology, being dynamic and listening to students. Additionally, administrators are realizing the significant importance of improving mental health, for both staff and students.

According to Brown, these changes are ambitious and will require a strategic overhaul of the learning experience. However, the culture shift that will result from it will undoubtedly increase the educational experience for all.

“I’ve never been prouder … this nation continued to move forward because of teachers in classrooms, bus drivers, tech specialists, principals, superintendents and school boards who every day, in the midst of crisis, were able to keep things going and take care of everyone,” Brown said. Educators were on the front line, and the world can’t forget that.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More